Breast Cancer,Esophageal Cancer,Gastric Cancer,Gastrointestinal Cancer,HER2- Phase 1 Study of BLU-222 in Advanced Solid Tumors Sep 26, 2023
Breast Cancer,HER2- Neoadjuvant Zanidatamab Is Safe And Effective In Stage I Node Negative HER2+ BC Sep 15, 2023
Breast Cancer,HER2- Autologous TAC01-HER2 Proves Safe And Effective In Relapsed Or Refractory Solid Tumors Sep 12, 2023
Breast Cancer,HER2-,TNBC (Triple Negative Breast Cancer) Interim Analysis of Phase III SASCIA Trial on SG in High-Risk HER2-Negative BC Jun 30, 2023
Breast Cancer,HER2+ Margetuximab vs Trastuzumab in Pretreated ERBB2-Positive Advanced Breast Cancer Jun 08, 2023
Breast Cancer,HER2+ Examining the Potential of Margetuximab in the Treatment of HER2+ Metastatic Breast Cancer May 19, 2023
Breast Cancer,HER2- BioItaLEE Trial: The Role of ctDNA and TKa in HR+, HER2- Advanced Breast Cancer Patients May 19, 2023